{"id":814914,"date":"2025-02-19T09:16:46","date_gmt":"2025-02-19T14:16:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/"},"modified":"2025-02-19T09:16:46","modified_gmt":"2025-02-19T14:16:46","slug":"autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/","title":{"rendered":"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference"},"content":{"rendered":"
\n

\n
\n
\n On-demand video webcast now available here<\/u>
\n <\/em>
\n <\/a>\n <\/p>\n

\n THE WOODLANDS, TX, Feb. 19, 2025 (GLOBE NEWSWIRE) — <\/strong>
\n
\n Autonomix Medical, Inc.<\/u>
\n <\/a>\u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing precision nerve-targeted treatments, today announced it participated in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference<\/u><\/a>.<\/p>\n

As part of the event, Brad Hauser, President and Chief Executive Officer of Autonomix, presented the top five reasons of why he believes the investment community and industry colleagues should pay attention to Autonomix in 2025.<\/p>\n

The on-demand video webcast is now accessible for viewing here<\/u><\/a> and on the Events<\/u><\/a> page in the Investors<\/u><\/a> section of the Company\u2019s website (<\/u>autonomix.com<\/u><\/a>).<\/u><\/p>\n

\n About Autonomix Medical, Inc.<\/strong>\n <\/p>\n

Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company\u2019s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.<\/p>\n

We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.<\/p>\n

For more information, visit autonomix.com<\/u><\/a> and connect with the Company on X<\/u><\/a>, LinkedIn<\/u><\/a>, Instagram<\/u><\/a> and Facebook<\/u><\/a>.<\/p>\n

\n Forward Looking Statements<\/strong>\n <\/p>\n

Some of the statements in this release are \u201cforward-looking statements,\u201d which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the potential of the technology to treat cancerous tumors and the pain associated with pancreatic cancer. Such forward-looking statements can be identified by the use of words such as \u201cshould,\u201d \u201cmight,\u201d \u201cmay,\u201d \u201cintends,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201cprojects,\u201d \u201cforecasts,\u201d \u201cexpects,\u201d \u201cplans,\u201d and \u201cproposes.\u201d<\/p>\n

Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading \u201cRisk Factors\u201d and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on May 31, 2024 and the Offering Prospectus filed with the SEC on November 25, 2024, and in other filings made by us from time to time with the SEC. Forward-looking statements speak only as of the date of the document in which they are contained and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.<\/p>\n

\n Investor and Media Contact<\/strong>
\n
JTC Team, LLC
Jenene Thomas
908.824.0775
autonomix@jtcir.com<\/u><\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

On-demand video webcast now available here THE WOODLANDS, TX, Feb. 19, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. \u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing precision nerve-targeted treatments, today announced it participated in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference. As part of the event, Brad Hauser, President and Chief Executive Officer of Autonomix, presented the top five reasons of why he believes the investment community and industry colleagues should pay attention to Autonomix in 2025. The on-demand video webcast is now accessible for viewing here and on the Events page in the Investors section of the Company\u2019s website (autonomix.com). About Autonomix Medical, Inc. Autonomix is a medical device company focused on … <\/p>\n

Continue reading “Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-814914","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAutonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"On-demand video webcast now available here THE WOODLANDS, TX, Feb. 19, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. \u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing precision nerve-targeted treatments, today announced it participated in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference. As part of the event, Brad Hauser, President and Chief Executive Officer of Autonomix, presented the top five reasons of why he believes the investment community and industry colleagues should pay attention to Autonomix in 2025. The on-demand video webcast is now accessible for viewing here and on the Events page in the Investors section of the Company\u2019s website (autonomix.com). About Autonomix Medical, Inc. Autonomix is a medical device company focused on … Continue reading "Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-19T14:16:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDY4NyM2NzU3NDA0IzUwMDExOTk5Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference\",\"datePublished\":\"2025-02-19T14:16:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/\"},\"wordCount\":508,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MDY4NyM2NzU3NDA0IzUwMDExOTk5Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/\",\"name\":\"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MDY4NyM2NzU3NDA0IzUwMDExOTk5Mg==\",\"datePublished\":\"2025-02-19T14:16:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MDY4NyM2NzU3NDA0IzUwMDExOTk5Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MDY4NyM2NzU3NDA0IzUwMDExOTk5Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/","og_locale":"en_US","og_type":"article","og_title":"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference - Market Newsdesk","og_description":"On-demand video webcast now available here THE WOODLANDS, TX, Feb. 19, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. \u00a0(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing precision nerve-targeted treatments, today announced it participated in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference. As part of the event, Brad Hauser, President and Chief Executive Officer of Autonomix, presented the top five reasons of why he believes the investment community and industry colleagues should pay attention to Autonomix in 2025. The on-demand video webcast is now accessible for viewing here and on the Events page in the Investors section of the Company\u2019s website (autonomix.com). About Autonomix Medical, Inc. Autonomix is a medical device company focused on … Continue reading \"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-19T14:16:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDY4NyM2NzU3NDA0IzUwMDExOTk5Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference","datePublished":"2025-02-19T14:16:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/"},"wordCount":508,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDY4NyM2NzU3NDA0IzUwMDExOTk5Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/","name":"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDY4NyM2NzU3NDA0IzUwMDExOTk5Mg==","datePublished":"2025-02-19T14:16:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDY4NyM2NzU3NDA0IzUwMDExOTk5Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MDY4NyM2NzU3NDA0IzUwMDExOTk5Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-participates-in-the-virtual-investor-top-5-for-25-on-demand-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Autonomix Medical, Inc. Participates in the Virtual Investor \u201cTop 5 for \u201825\u201d On-Demand Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814914","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=814914"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814914\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=814914"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=814914"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=814914"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}